Annual Cash & Cash Equivalents
$86.10 M
+$64.10 M+291.47%
December 31, 2023
Summary
- As of February 12, 2025, EWTX annual cash & cash equivalents is $86.10 million, with the most recent change of +$64.10 million (+291.47%) on December 31, 2023.
- During the last 3 years, EWTX annual cash & cash equivalents has fallen by -$18.82 million (-17.94%).
- EWTX annual cash & cash equivalents is now -17.94% below its all-time high of $104.92 million, reached on December 31, 2020.
Performance
EWTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$44.81 M
+$1.32 M+3.04%
September 30, 2024
Summary
- As of February 12, 2025, EWTX quarterly cash and cash equivalents is $44.81 million, with the most recent change of +$1.32 million (+3.04%) on September 30, 2024.
- Over the past year, EWTX quarterly cash and cash equivalents has increased by +$11.85 million (+35.95%).
- EWTX quarterly cash and cash equivalents is now -79.73% below its all-time high of $221.04 million, reached on March 31, 2021.
Performance
EWTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EWTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +291.5% | +36.0% |
| 3 y3 years | -17.9% | +36.0% |
| 5 y5 years | +264.0% | +36.0% |
EWTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +453.1% | -59.2% | +187.8% |
| 5 y | 5-year | -17.9% | +453.1% | -79.7% | +323.9% |
| alltime | all time | -17.9% | +453.1% | -79.7% | +323.9% |
Edgewise Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $44.81 M(+3.0%) |
| Jun 2024 | - | $43.48 M(+43.7%) |
| Mar 2024 | - | $30.26 M(-64.8%) |
| Dec 2023 | $86.10 M(+291.5%) | $86.10 M(+161.2%) |
| Sep 2023 | - | $32.96 M(+3.6%) |
| Jun 2023 | - | $31.81 M(-34.1%) |
| Mar 2023 | - | $48.23 M(+119.3%) |
| Dec 2022 | $21.99 M | $21.99 M(-80.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $109.75 M(+498.4%) |
| Jun 2022 | - | $18.34 M(-46.8%) |
| Mar 2022 | - | $34.45 M(+121.3%) |
| Dec 2021 | $15.57 M(-85.2%) | $15.57 M(+47.3%) |
| Sep 2021 | - | $10.57 M(-79.0%) |
| Jun 2021 | - | $50.40 M(-77.2%) |
| Mar 2021 | - | $221.04 M(+110.7%) |
| Dec 2020 | $104.92 M(+343.6%) | $104.92 M |
| Dec 2019 | $23.65 M | - |
FAQ
- What is Edgewise Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
- What is Edgewise Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Edgewise Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of EWTX is $86.10 M
What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual cash & cash equivalents is $104.92 M
What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, EWTX annual cash & cash equivalents has changed by +$64.10 M (+291.47%)
What is Edgewise Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EWTX is $44.81 M
What is the all time high quarterly cash and cash equivalents for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly cash and cash equivalents is $221.04 M
What is Edgewise Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, EWTX quarterly cash and cash equivalents has changed by +$11.85 M (+35.95%)